Should men with mild erectile dysfunction be closely evaluated for cardiovascular diseases in the Korean population?

References

• Chang ST, Chu CM, Hsu JT, et al. Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity. Int J Impot Res 2009;21:116–21
   PubMedGoogle Scholar
• Schouten BW, Bohnen AM, Bosch JL, et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. Int J Impot Res 2008;20:92–9
   PubMed Web of Science ®Google Scholar
• Ponholzer A, Temml C, Obermayr R, et al. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005;48:512–8; discussion 517–8
   PubMed Web of Science ®Google Scholar
• El-Sakka AI, Morsy AM, Fagih BI, Nassar AH. Coronary artery risk factors in patients with erectile dysfunction. J Urol 2004;172:251–4
   PubMed Web of Science ®Google Scholar
• Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 2003;44:360–4; discussion 364–5
   PubMed Web of Science ®Google Scholar
• Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–26
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346–51
   PubMed Web of Science ®Google Scholar
• Chew KK, Bremner A, Jamrozik K, et al. Male erectile dysfunction and cardiovascular disease: is there an intimate nexus? J Sex Med 2008;5:928–34
   PubMedGoogle Scholar
• Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005;47:80–5; discussion 85–6
   PubMed Web of Science ®Google Scholar
• Khoo EM, Tan HM, Low WY. Erectile dysfunction and comorbidities in aging men: an urban cross-sectional study in Malaysia. J Sex Med 2008;5:2925–34
   PubMed Web of Science ®Google Scholar
• Lee JC, Benard F, Carrier S, et al. Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population? BJU Int 2011;107:956–60
   PubMedGoogle Scholar
• Fisher WA, Rosen RC, Eardley I, et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004;1:150–60
   PubMed Web of Science ®Google Scholar
• Zhao C, Kim SW, Yang DY, et al. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2011;60:380–7
   PubMed Web of Science ®Google Scholar
• Paick JS, Kim SW, Yang DY, et al. The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. J Sex Med 2008;5:946–53
   PubMed Web of Science ®Google Scholar
• Park HJ, Park JK, Park K, et al. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial. J Sex Med 2010;7:2209–16
   PubMed Web of Science ®Google Scholar
• Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007;26:734–53
   PubMed Web of Science ®Google Scholar
• Donovan JL, Abrams P, Peters TJ, et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996;77:554–62
   PubMedGoogle Scholar
• Solomon H, Man JW, Wierzbicki AS, Jackson G. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 2003;91:230–1
   PubMed Web of Science ®Google Scholar
• Ma RC, So WY, Yang X, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008;51:2045–50
   PubMed Web of Science ®Google Scholar
• Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 2004;16:350–3
   PubMed Web of Science ®Google Scholar
• Benard F, Carrier S, Lee JC, et al. Men with mild erectile dysfunction benefit from sildenafil treatment. J Sex Med 2010;7:3725–35
   PubMedGoogle Scholar
• Sommer F, Klotz T, Engelmann U. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial. Asian J Androl 2007;9:134–41
   PubMed Web of Science ®Google Scholar
• Jee SH, Appel LJ, Suh I, et al. Prevalence of cardiovascular risk factors in South Korean adults: results from the Korea Medical Insurance Corporation (KMIC) Study. Ann Epidemiol 1998;8:14–21
   PubMedGoogle Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090–101
   PubMed Web of Science ®Google Scholar
• Fung MM, Bettencourt R, Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol 2004;43:1405–11
   PubMed Web of Science ®Google Scholar
• Jackson G, Boon N, Eardley I, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract 2010;64:848–57
   PubMed Web of Science ®Google Scholar
• Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012;87:766–78
   PubMed Web of Science ®Google Scholar